OR WAIT null SECS
© 2022 MJH Life Sciences and Optometry Times. All rights reserved.
© 2022 MJH Life Sciences™ and Optometry Times. All rights reserved.
October 05, 2022
A recent report shows that 61 drugs were associated with the development of acute angle-closure (AAC) glaucoma.
October 04, 2022
Potential for treatment strategy to prevent blindness from glaucoma.
September 26, 2022
Recent patient situation stresses needs for peer-to-peer discourse.
September 18, 2022
As technology improves, less-invasive treatments save patients time and money.
September 16, 2022
Mitch Ibach, OD, FAAO, shares highlights from his VEW 2022 presentation, "Visual fields, a virtual reality."
Melissa Barnett, OD, from the University of California, Davis Eye Center, Sacramento and Davis, CA, described new strategies, technologies, and drug classes to treat chronic conditions that include myopia, Demodex infestation, meibomian gland dysfunction, glaucoma drug delivery, advancements in corneal and cataract surgeries, and presbyopia
Optometrists are seeing recent advances in topical therapies that entered the market following decades of reliance of traditional single-agent drops. An implantable device that facilitates the slow release of drug is changing the landscape in glaucoma therapy.
September 15, 2022
Justin Schweitzer, OD, FAAO, reports that glaucoma therapy is quickly moving to more innovative and targeted ways to treat glaucoma and lower the patient treatment burden.
Michael Chaglasian, OD, Illinois College of Optometry, Chicago, and Eric Schmidt, OD, Omni Eye Specialists, Wilmington, NC, share guidelines for ODs on diagnosing glaucoma during the 2022 Vision Expo West in Las Vegas.
September 14, 2022
Jessica Steen, OD, FAAO, shares highlights from her VEW 2022 presentation, "Ophthalmic therapeutics update."
Black EyeCare Perspective to host third annual IMPACT HBCU event
Online visual acuity test gains FDA clearance
Debunking common ortho-k myths
Recent study evaluates medications associated with AAC glaucoma risk